THE LATEST WORD

Top Industry Stories – July 30, 2010

Posted on July 30th, 2010 | by Rxmedyn | No Comments »

Damp House Linked to Kids’ Risk of Nasal Allergies

Novo Nordisk, Lilly, Novartis Said to be Among Bidders for Ascendis Pharma

Novartis Exploits J&J Recall Pains with Triaminic Giveaway

Cuvposa Approved for Chronic Drooling in Children

Story-Telling More Difficult for Brain-Injured Children: Study

Read the rest of this entry »

Top Industry Stories – July 29, 2010

Posted on July 29th, 2010 | by Rxmedyn | No Comments »

Sanofi-Aventis Said to be Likely to Bid $18 Billion for Genzyme

Census Data Reveal Broad Differences Among States in Rates of Uninsured

Bystander CPR – No Breaths Necessary, Studies Say

FDA Considering Changes to Risky Drug Safeguards

Americans Still Confused About Health Reform

Read the rest of this entry »

Top Industry Stories – July 28, 2010

Posted on July 28th, 2010 | by Rxmedyn | No Comments »

FDA Taps Buckmann to Lead Online Drug Comms

Advisory Panel Rebuffs FDA Risk-Mgmt. Plan for Pain Meds

Are Kids’ ER Visits for Food Allergies on the Rise?

New Health Policy: Encouraging Friendships

Merck in Talks for China Partnership

Read the rest of this entry »

Top Industry Stories – July 27, 2010

Posted on July 27th, 2010 | by Rxmedyn | No Comments »

Modest Weight Loss May Curb Urine Leakage

Teva Earnings Climb on Higher U.S. Drug Sales

Genzyme Said to Rebuff Sanofi-Aventis Takeover Approach

Sanofi Looks to Block Generic Lovenox in Court

US Sentte Bill Rejects Ban on Generic Drug Deals

Read the rest of this entry »

Top Industry Stories – July 26, 2010

Posted on July 26th, 2010 | by Rxmedyn | No Comments »

What ‘Clinically Proven’ Means For A Beauty Product

FDA Approves Larger Dose of Pfizer’s Aricept

Sanofi Cuts Outlook After FDA Approves Lovenox Copy

Roche’s Genetech License NovImmune Antibody for Auto-Immune Diseases

Medical Device Problems Hurt 70,000+ Kids Annually

Read the rest of this entry »

Top Industry Stories – July 23, 2010

Posted on July 23rd, 2010 | by Rxmedyn | No Comments »

Gilead AIDS Drug Safe for HIV Prevention in Study

New Pain Meds Pose Tricky PR Test, as FDA Gaffe Shows

Consumer Gene Test Results Misleading: U.S. Probe

J&J AIDS Drug Shows Promise

DDMAC Regulatory Letters Could Double in 2010

Read the rest of this entry »

Top Industry Stories – July 22, 2010

Posted on July 22nd, 2010 | by Rxmedyn | No Comments »

FDA ‘Must Publish All Safety, Efficacy Data From Drug Apps’

New Guidelines Aim to Encourage Vaginal Births After C-Sections

FDA Report Details JNJ’s Quality Issues

Study Raises Hope for Safer Diabetes Drugs

Blue Cross Reaps Surpluses While Rates Rise: Report

Read the rest of this entry »

Top Industry Stories – July 21, 2010

Posted on July 21st, 2010 | by Rxmedyn | No Comments »

F.D.A. Panel Urges Limits for Avastin

AIDS Gel with Gilead Drug Protects Women in Study

Researchers Find a Way to Take the ‘Shot’ Out of the Flu Shot

FDA Takes Fresh Look at MannKind’s Inhaled Insulin

Glaxo Is Said to Have Paid $1 Billion to Resolve Paxil Birth-Defect Suits

Read the rest of this entry »

Top Industry Stories – July 16, 2010

Posted on July 16th, 2010 | by Rxmedyn | No Comments »

Health Plans Must Provide Some Tests at No Cost

Two-Step Vaccine May Offer ‘Universal’ Flu Jab

Stroke Risk May Rise First Hour After Drinking

Evotec Buys DeveloGen and its Boehringer, Teva Alliances

F.D.A. Panel Votes Against Obesity Drug

Top Industry Stories – July 15, 2010

Posted on July 15th, 2010 | by Rxmedyn | No Comments »

F.D.A. Panel Votes to Restrict Avandia

Suicide Tied To Air Pollution and Asthma

Insulin Via Nasal Spray Shows Benefit In Alzheimer’s Patients

Just a Cough, or Lung Cancer?

California Supremes Say Pharma Must Face Price-Fixing Charges

Read the rest of this entry »